Information  X 
Enter a valid email address

United Drug PLC (UDG)

  Print      Mail a friend       Annual reports

Tuesday 06 September, 2011

United Drug PLC

Purchase of Own Securities

RNS Number : 6623N
United Drug PLC
06 September 2011
 

 

 

UNITED DRUG PLC

('United Drug' or 'the Company')

 

Purchase of Own Securities

 

 

United Drug announces that on 5 September 2011, its broker Davy purchased 52,125 Ordinary Shares of nominal value €0.05 each in the capital of the Company ("Ordinary Shares") on behalf of the Company. The price paid for these Ordinary Shares was €2.2317 per share.

 

The 52,125 Ordinary Shares will be cancelled. Following the cancellation of these shares, the Company's issued share capital will reduce from 239,669,632 to 239,617,507. Each Ordinary Share carries one vote. United Drug also holds 7,528,066 Ordinary Shares in treasury, which do not carry voting rights. 

 

 

Ends                                         6 September 2011

 

 

 

Contact:

Karen Geoghegan

United Drug plc

Tel: +353-1-4637720

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUVRNRARAKRAR